FY2025 · ended Dec 31, 2025 · Revenue $0, -100.0% YoY · Filed Feb 19, 2026
Praxis Precision Medicines, Inc. (PRAX) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $303.3 million. Free cash flow was -$249.1 million. As of Jun 30, 2026 it held $1.4 billion in cash and investments and $1.4 million in total debt.
Revenue
$0
-100.0% vs prior year
Net income
$-303.27M
-65.9% vs prior year
Operating cash flow (TTM)
$-305.08M
-59.5% vs year-ago TTM
Free cash flow (TTM)
$-305.38M
EPS
$-13.48
-32.0% vs prior year
Dividend per share
None
Shares outstanding
27.85M
+38.1% vs prior year
Net cash
$1.37B
as of Jun 30, 2026
Operating margin
-2340.3%
FY 2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1689548
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $8.6M | $2.4M | — | — |
| Operating income | -$326.2M | -$200.2M | -$126.4M | -$215.0M | -$167.3M |
| Net income | -$303.3M | -$182.8M | -$123.3M | -$214.0M | -$167.1M |
| Diluted EPS | -$13.48 | -$10.21 | -$18.69 | -$69.65 | -$3.94 |
| Operating cash flow | -$249.1M | -$131.8M | -$111.1M | -$185.0M | -$124.6M |
| Free cash flow | -$249.1M | -$131.8M | -$111.2M | -$185.5M | -$125.6M |
| Total assets | $937.9M | $483.1M | $87.9M | $115.1M | $292.7M |
| Total liabilities | $59.8M | $37.7M | $18.3M | $39.0M | $41.9M |
| Stockholders' equity | $878.1M | $445.4M | $69.7M | $76.1M | $250.8M |
| Cash and investments | $926.1M | $646.7M | $81.3M | $100.5M | $275.9M |
| Total debt | $110,000 | $1.4M | $2.5M | $3.5M | $4.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Other events
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 2, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 22, 2026 | Jun 22, 2026 |
All 510 Praxis Precision Medicines, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.